NanoVibronix logo.png
NanoVibronix Reports Second Quarter 2021 Financial Results; Provides Business Update
August 16, 2021 16:05 ET | NanoVibronix, Inc.
ELMSFORD, N.Y., Aug. 16, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV), a healthcare device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable...
NAOV Logo.png
NanoVibronix Receives Reimbursement Approval from U.S. Centers for Medicare & Medicaid Services (CMS) for PainShield™
April 01, 2020 08:00 ET | NanoVibronix, Inc.
ELMSFORD, N.Y., April 01, 2020 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® Surface Acoustic Wave (SAW) Portable Ultra Sonic...
NAOV Logo.png
NanoVibronix looks to expand use of its UroShield Due to the potential to impact comorbidities related to COVID-19 Crisis
March 27, 2020 09:41 ET | NanoVibronix, Inc.
ELMSFORD, N.Y., March 27, 2020 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® Surface Acoustic Wave (SAW) Portable Ultra Sonic...
NAOV Logo.png
NanoVibronix Announces Closing of $3.2 Million Private Placement
June 24, 2019 17:42 ET | NanoVibronix, Inc.
ELMSFORD, N.Y., June 24, 2019 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® surface acoustic wave (SAW) device, which utilizes the...
NAOV Logo.png
NanoVibronix Announces Planned Launch of CBD Patch and Cream for PainShield® Designed to Amplify Therapeutic Effect
June 05, 2019 08:30 ET | NanoVibronix, Inc.
Combination of nanoparticle CBD-infused patch/cream and PainShield® intended as powerful alternative to opioids for treatment of pain NanoVibronix partnering with Saralex Group for regulatory...
NanoVibronix.jpg
NanoVibronix Announces Publication of PainShield™ Trigeminal Neuralgia Study in the Journal of Anesthesiology and Pain Research
February 25, 2019 08:00 ET | NanoVibronix, Inc.
55.2% improvement in baseline pain scores versus 2.3% for the control group 46.4% reduction in breakthrough pain medication, including opioids, versus 1.5% versus for the treatment group PainShield™...
NanoVibronix.jpg
NanoVibronix Enters Collaboration Agreement with Fritz Clinic to Offer PainShield® as an Alternative to Opioids for Pain Management
January 11, 2019 08:00 ET | NanoVibronix, Inc.
ELMSFORD, N.Y., Jan. 11, 2019 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave...
NanoVibronix.jpg
NanoVibronix Announces Expanded Agreement with MDS Pharm Ltd. to Include Distribution of UroShield® in Israel
December 27, 2018 08:00 ET | NanoVibronix, Inc.
ELMSFORD, N.Y., Dec. 27, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave...
NanoVibronix.jpg
NanoVibronix Signs Major Distributor in India for UroShield®
December 20, 2018 08:00 ET | NanoVibronix, Inc.
ELMSFORD, N.Y., Dec. 20, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave...
NanoVibronix.jpg
NanoVibronix Signs with Exclusive Distributor in Switzerland for UroShield®
December 18, 2018 09:25 ET | NanoVibronix, Inc.
ELMSFORD, N.Y., Dec. 18, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave...